Drug Type Small molecule drug |
Synonyms (1-hydroxy-ethylidene)diphosphonic acid, (1-Hydroxyethylene)diphosphonic acid, (1-Hydroxyethylidene)bis(phosphonic acid) + [35] |
Target |
Action inhibitors |
Mechanism Bone resorption factor inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date United States (01 Sep 1977), |
RegulationOrphan Drug (United States), Orphan Drug (European Union) |
Molecular FormulaC2H8Na2O7P2 |
InChIKeyFCBYKAIUKRZZGW-UHFFFAOYSA-N |
CAS Registry7414-83-7 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D00314 | Etidronate Disodium |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Ossification, Heterotopic | Japan | 28 Sep 1990 | |
| Osteoporosis | United States | 01 Sep 1977 | |
| Osteitis Deformans | United States | 01 Sep 1977 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Pseudoxanthoma Elasticum | Phase 3 | Netherlands | 26 Apr 2023 | |
| Fahr's Disease | Phase 2 | Netherlands | 03 Apr 2023 | |
| Fahr's Disease | Phase 2 | United Kingdom | 03 Apr 2023 | |
| HEM Dysplasia | Phase 2 | Netherlands | 03 Apr 2023 | |
| HEM Dysplasia | Phase 2 | United Kingdom | 03 Apr 2023 | |
| ABCC6 deficiency | Preclinical | European Union | 11 Oct 2022 |
Phase 2 | 7 | MRI Scan+Etidronate | zfkgryvtpi(oqyfoouiks) = wavslmmuym ttfvtgoteg (lpnrtyjrsh, lbszopfail - elhhmuffch) View more | - | 04 Oct 2022 |





